Literature DB >> 456231

Effects of long-term cimetidine on serum gastrin in duodenal ulcer.

J Hansky, A I Stern, M G Korman, J Waugh.   

Abstract

Basal and food-stimulated gastrin were measured in 16 patients with duodenal ulcer before and during long-term maintenance therapy with 400 mg cimetidine twice daily. Basal gastrin (mean +/- SE) rose significantly from 27.5 +/- 3.1 pmol/liter precimetidine to 32.8 +/- 2.1, 37.2 +/- 2.6, and 38.5 +/- 3.3 pmol/liter at 1, 3, and 6 months, respectively. The total integrated gastrin response to a protein meal was 1.67 +/- 0.18 nmol/liter/120 min pre-, and 2.54 +/- 0.35, 3.29 +/- 0.3, and 4.36 +/- 0.4 nmol/liter/120 min at 1, 3, and 6 months, respectively. These increases were significantly higher at each time period. This study has thus demonstrated a progressive increase in both basal and food-stimulated gastrin during cimetidine therapy, and this increase could theoretically lead to an increase in gastric acid secretion following cessation of cimetidine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 456231     DOI: 10.1007/bf01299830

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat.

Authors:  L Witzel; F Halter; A J Olah; W H Häcki
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

2.  Effect of food on serum gastrin evaluated by radioimmunoassay.

Authors:  M G Korman; C Soveny; J Hansky
Journal:  Gut       Date:  1971-08       Impact factor: 23.059

3.  The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer.

Authors:  C T Richardson; J H Walsh; M I Hicks
Journal:  Gastroenterology       Date:  1976-07       Impact factor: 22.682

4.  Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration: a review.

Authors:  C T Richardson
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

5.  Effect of secretin on serum gastrin as measured by immunoassay.

Authors:  J Hansky; C Soveny; M G Korman
Journal:  Gastroenterology       Date:  1971-07       Impact factor: 22.682

6.  Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.

Authors:  R M Henn; J I Isenberg; V Maxwell; R A Sturdevant
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

7.  Effect of one-month treatment with cimetidine on gastric secretion and serum gastrin and pepsinogen levels.

Authors:  K F Sewing; L Hagie; A F Ippoliti; J I Isenberg; I M Samloff; R A Sturdevant
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

8.  Progressive increase in the functional G cell mass with age in atrophic gastritis.

Authors:  M G Korman; J Hansky; R G Strickland
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

9.  Serum gastrin and the antral mucosa in atrophic gastritis.

Authors:  R G Strickland; P S Bhathal; M G Korman; J Hansky
Journal:  Br Med J       Date:  1971-11-20
  9 in total
  11 in total

1.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.

Authors:  J G Penston; K G Wormsley
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

3.  Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer.

Authors:  J E McGuigan; Y Chang; E Z Dajani
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

4.  Twenty four hour intragastric acidity analysis for the future.

Authors:  R Walt
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

5.  Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.

Authors:  S Brozinsky; D L Hogan; J I Isenberg; C T Richardson
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

Review 6.  Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials.

Authors:  G Dobrilla; P Vallaperta; S Amplatz
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

7.  Peptic ulcer disease: the flowers that bloom in the spring.

Authors: 
Journal:  West J Med       Date:  1981-09

8.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

9.  Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.

Authors:  M Quatrini; G Basilisco; P A Bianchi
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

10.  Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients.

Authors:  E G Hewson; N D Yeomans; P W Angus; A Shulkes; C W Brook; R B Sewell; R A Smallwood
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.